Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

783
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
783
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

455
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
455
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

482
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
482
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.6K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.6K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

651
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
651

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mepolizumab Efficacy in COPD: Insights from Longitudinal Patterns of Blood Eosinophil Counts and Their Variability Across Three Clinical Trials.

American journal of respiratory and critical care medicine·2026
Same author

Stiffness-dependent alveolar type II cell senescence in idiopathic pulmonary fibrosis.

Cell communication and signaling : CCS·2026
Same author

Prevalence of the phenotype of lung hyperinflation and minimal emphysema in COPD.

American journal of respiratory and critical care medicine·2026
Same author

Hair follicle gene expression profiling in the SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIROMICS).

BMC medical genomics·2025
Same author

Emphysema detection by qualitative and quantitative analysis and relationship to spirometric obstruction in an urban comprehensive lung cancer screening programme: the Temple Healthy Chest Initiative (THCI) - a retrospective cohort study.

BMJ open·2025
Same author

The ROME COPD exacerbation proposal works! Time to move forward.

American journal of respiratory and critical care medicine·2025
Same journal

How artificial intelligence could improve the diagnosis and management of COPD: a perspective from GOLD.

American journal of respiratory and critical care medicine·2026
Same journal

Awake ECMO for ARDS: No Vent, No VILI, No Problem?

American journal of respiratory and critical care medicine·2026
Same journal

Microbiome-Targeted Antibiotics Provide No Additional Microbiologic or Inflammatory Benefit during Cystic Fibrosis Pulmonary Exacerbations: Results from the CFMATTERS Trial.

American journal of respiratory and critical care medicine·2026
Same journal

Noninvasive Respiratory Support for Adult Patients with Acute Respiratory Failure. An Official American Thoracic Society Clinical Practice Guideline.

American journal of respiratory and critical care medicine·2026
Same journal

Respiratory effort during sleep predicts mortality in patients with suspected obstructive sleep apnea.

American journal of respiratory and critical care medicine·2026
Same journal

Beyond the Trials: Real-World Insights into Tezepelumab Efficacy.

American journal of respiratory and critical care medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 11, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

870

Submassive Pulmonary Embolism.

Parth M Rali1, Gerard J Criner1

  • 1Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania.

American Journal of Respiratory and Critical Care Medicine
|April 20, 2018
PubMed
Summary
This summary is machine-generated.

Submassive pulmonary embolism (PE) management requires coordinated care due to potential deterioration and comorbidities. This review details PE definitions, risk stratification, and treatment strategies, emphasizing the PE response team’s role.

Keywords:
catheter-directed thrombolysisintermediate pulmonary embolismpulmonary embolism response teampulmonary embolism risk stratificationsubmassive pulmonary embolism

More Related Videos

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

857
Induction of Cerebral Arterial Gas Embolism in Rat
06:26

Induction of Cerebral Arterial Gas Embolism in Rat

Published on: October 18, 2024

899

Related Experiment Videos

Last Updated: Feb 11, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

870
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

857
Induction of Cerebral Arterial Gas Embolism in Rat
06:26

Induction of Cerebral Arterial Gas Embolism in Rat

Published on: October 18, 2024

899

Area of Science:

  • Cardiology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Pulmonary embolism (PE) encompasses a range of hemodynamic effects, from asymptomatic cases to life-threatening emergencies.
  • Managing submassive and massive PE often involves multidisciplinary teams, potentially delaying unified treatment plans.
  • Patients with submassive PE may deteriorate, necessitating escalated care, especially with comorbidities like COPD, cancer, or heart failure.

Purpose of the Study:

  • To review definitions, risk stratification, and management strategies for submassive PE.
  • To discuss the impact of comorbidities on hemodynamic tolerance in submassive PE.
  • To explore the role of Pulmonary Embolism Response Teams (PERT) in patient management.

Main Methods:

  • Literature review focusing on submassive PE.
  • Analysis of clinical, laboratory, and imaging risk stratification methods.
  • Discussion of current and emerging management approaches.

Main Results:

  • Submassive PE presents varied hemodynamic challenges influenced by comorbidities.
  • Effective risk stratification is crucial for timely and appropriate intervention.
  • Multidisciplinary approaches, including PERT, are vital for optimizing outcomes.

Conclusions:

  • Coordinated, multidisciplinary management is essential for submassive PE.
  • Risk stratification guides treatment escalation and resource allocation.
  • The role of PERT is increasingly important in managing complex PE cases.